Pharma Cash to Congress
A KFF Health News database tracks campaign donations from drugmakers over the past 10 years.
The independent source for health policy research, polling, and news.
KFF Health News aims for accountability and transparency in health reporting — and here is a chance for you to search data and documents that shed light on the quality of U.S. health care, as well as influencers on the health care system. Our reporters have compiled databases and documents that are exclusive to KFF Health News — and free for you to explore and share.
A KFF Health News database tracks campaign donations from drugmakers over the past 10 years.
The South Carolina senator led the congressional pack in pharma campaign contributions for the second half of 2021. There are clear reasons.
Find easy-to-read charts and downloadable data sets that show Medicare’s financial actions for hospitals throughout the country.
Penalties will total $566 million for all hospitals. But many that serve a large share of low-income patients will lose less money than they did in previous years.
Purdue Pharma planned an extensive marketing campaign for the launch and promotion of the painkiller OxyContin. Here are Purdue’s internal budget documents from 1996 to 2002 — files released by the Florida attorney general’s office — that detail the company’s early strategy to sell and expand use of the drug.
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration. But do they represent patients or Big Pharma? KFF Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups.
Kaiser Health News launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.
Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
Use this tool to see how skilled nursing homes in the U.S. performed on two metrics of quality.
Daily nursing home payroll records just released by the federal government show the number of nurses and aides dips far below average on some days and consistently plummets on weekends.